Figure 10.
Proposed mechanisms of action of BRAFi (vemurafenib, dabrafenib) and RIPK4 on the RAF1/MEK/ERK pathway and proliferation in melanoma cells with BRAFV600.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.